Speaker
Chairman & Co-Founder, Degrome Therapeutics
Chunhai Hao, Chairman & Co-Founder at Degrome Therapeutics, spoke at 9th TPD & Induced Proximity Summit (Boston, United States of America, 26–29 Oct 2026) in the session “Molecular Glue Degraders Enhance CAPRIN1-Dependent Lysosomal Degradation of APP & Reduce Amyloid in Alzheimer’s Disease”.
26–29 Oct 2026Boston, United States of America
Professor, Harvard Medical School
President & Chief Executive Officer, Arvinas, Inc.
Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co
Associate Director, Medicinal Chemistry, AstraZeneca
Science Partner, Flagship Pioneering
Chief Business Officer, Nurix Therapeutics, Inc.
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Chunhai Hao, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].